Please Wait.....
Report
Global Colorectal Cancer Screening and Diagnostics Market
Market Research Report I 2025-02-27 I 166 Pages I BCC Research
Description
Report Scope
This report summarizes the colorectal cancer screening and diagnostic testing service market, including a market snapshot and company profiles of leading product manufacturers/service providers. It provides a comprehensive market breakdown with in-depth information regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges, and opportunities. It provides information on emerging technologies and developments in the industry. The report also analyzes critical market players' financials, product portfolios, and recent activities.
BCC Research analyzed and made projections of each market and its applications, along with forecasts for the next five years. The report also features profiles of leading product manufacturers/service providers in the colorectal cancer screening and diagnostic testing service industry, including Fujifilm Holdings Corporation, Olympus Corporation, Exact Sciences Corporation, Danaher Corporation, Guardant Health, New Horizon Health, and Quest Diagnostics.
The market is segmented by geographical region into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Regional analysis is further segregated:
- North America: The U.S., Canada, and Mexico.
- Europe: Germany, the U.K., France, Italy, Spain, and the Rest of Europe.
- Asia-Pacific: China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific.
Data for market estimates have been provided for 2021 and 2022 as the historical years and 2023 as the base year, with the forecast through 2029.
Report Includes
- 37 data tables and 71 additional tables
- Analyses of trends in the global market for colorectal cancer screening and diagnostics, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Estimates and forecasts of the market size by type, end user and geographic region
- Discussion of emerging technologies and developments, and the macroeconomic factors affecting the market
- Coverage of stages, etiology, pathophysiology, and risk factors of colorectal cancer, and discussion on its diagnosis, regulatory framework and reimbursement scenarios
- Information on product pipeline, approvals, launches and expansions and funding and grants in the medical industry
- Review of patent data and other new developments
- Discussion of ESG challenges and practices of the industry
- Assessment of the competitive landscape, including the market shares of leading companies, their product portfolios and financial overviews
- Information on recent mergers and acquisitions, expansions, collaborations, investments, and divestments
- Company profiles of major players within the industry, including Fujifilm Holdings Corp., Olympus Corp., Exact Sciences Corp., Danaher Corp., and Guardant Health
Executive Summary
Summary:
The global market for colorectal cancer screening and diagnostic testing services is estimated to increase from $40.0 billion in 2024 to reach $46.1 billion by 2029, at a compound annual growth rate (CAGR) of 2.9% from 2024 through 2029.
In 2023, the global colorectal cancer screening and diagnostic testing service market was valued at $39.0 billion. The market is forecasted to grow at a compound annual growth rate (CAGR) of 2.9% to reach $46.1 billion by the end of 2029.
The increasing incidence of colorectal cancer, rise in demand for non-invasive colorectal cancer screening, growing need for early cancer detection to lower treatment cost, advances in genomics and molecular diagnostics, and rising financial burden on healthcare are key factors driving the market's growth. However, the limited sensitivity of non-invasive testing methods, sample collection challenges, and stringent regulations might hinder the market's growth in the next five years.
This report segments the global market by test type, end user, and region. By test type, the colonoscopy and sigmoidoscopy segment held the largest market share in 2023, and this segment is expected to grow at a CAGR of 1.7% during the forecast period.
In terms of end users, the hospital and clinic segment is forecast to grow at a CAGR of 2.6% during the forecast period. This segment dominated with 69.3% of the market in 2023 and is forecast to reach a value of $31.4 billion by the end of 2029.
North America held the largest regional market share, with 60.8% in 2023. An increasing number of screening tests for colorectal cancer coupled with the significant regional presence of key product manufacturers are responsible for a large share.
Leading product manufacturers in the global market include Fujifilm Holdings Corp., Olympus Corp., Exact Sciences Corp., Danaher Corp., Guardant Health, and New Horizon Health.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Insights
Chapter 2 Market Overview
Disease Area Overview
Stages of Colorectal Cancer
Stage 0
Stage I
Stage II
Stage III
Stage IV
Etiology
Genetic Factors
Environmental Factors
Pathophysiology
Germline Mutations
Sporadic Mutations
Metastasis
Clinical Implications
Risk Factors
Inherited Syndromes
Lynch Syndrome (HNPCC)
Familial Adenomatous Polyposis (FAP)
Diagnosis
Prognosis
Types of Colorectal Cancer
Colorectal Adenocarcinoma
Gastrointestinal Stromal Tumors (GISTs)
Carcinoids
Turcot Syndrome
Peutz-Jeghers Syndrome (PJS)
Familial Colorectal Cancer (FCC)
Juvenile Polyposis Syndrome (JPS)
Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)
MUTYH-Associated Polyposis (MAP)
Market Definition
Inclusion and Exclusion Criteria
Inclusion Criteria
Exclusion Criteria
Market Introduction
The Road Ahead
Global Prevalence of Colorectal Cancer
Industry Outlook: Regulatory Framework
Regulatory Framework in the U.S.
Regulatory Framework in Europe
Regulatory Framework in the Asia-Pacific Region
Regulatory Landscape in Latin America
Reimbursement Scenarios
Colonoscopy and Sigmoidoscopy Tests
Stool DNA Test
Fecal Immunochemical Tests (FIT)
Fecal Occult Blood Tests (FOBT)
Blood-based/Biomarker Tests
Product Pipeline
Comparison of Colorectal Cancer Screening and Diagnostic Tests
Colonoscopy Tests
Sigmoidoscopy Tests
Fecal Immunochemical Tests (FIT)
Guaiac Fecal Occult Blood Tests (gFOBT)
Stool DNA Tests
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Increasing Incidence of Colorectal Cancer
Growing Financial Burden
Advances in Genomics and Molecular Diagnostics
Rise in Demand for Non-Invasive Colorectal Cancer Screening
Growing Need for Early Cancer Detection to Lower Treatment Costs
Market Restraints
Limited Sensitivity of Non-Invasive Testing Methods
Sample Collection Challenges
Stringent Regulations
Market Opportunities
Global Expansion of Colorectal Cancer Screening Programs
Emerging Economies Proposing Significant Untapped Potential
Chapter 4 Emerging Technologies and Developments
Introduction
Multimodal Approaches to Colorectal Cancer Screening
Development of At-Home Colorectal Cancer Screening Kits
Emerging Use of Gut Microbiota in Colorectal Cancer Diagnosis
Adoption of Artificial Intelligence (AI)
Digital Health Interventions
Multicancer Detection (MCD) Assays
Development of Self-Propelled Colonoscopes
Aer-O-Scope Colonoscope
ColonoSight
Chapter 5 Market Segmentation Analysis
Key Market Trends
Segmentation Breakdown
Global Market for Colorectal Cancer Screening and Diagnostic Testing Services
Market Analysis by Test Type
Colonoscopy and Sigmoidoscopy Tests
Stool DNA Tests
Market Size and Forecast
Blood-Based/Biomarker Tests
Fecal Occult Blood Tests (FOBT)
Fecal Immunochemical Tests (FIT)
Market Analysis by End User
Hospitals and Clinics
Diagnostic Laboratories
Ambulatory Centers
At-home Care
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific Region
Rest of the World
Chapter 6 Competitive Intelligence
Competitive Landscape
Partnerships and Collaborations
Acquisitions
Business Expansions
Funding and Grants
Product Approvals, Launches and Expansions
Regulatory and Legal Activities
Medicare and Insurance Coverage
Chapter 7 Sustainability in the Colorectal Cancer Screening and Diagnostic Testing Service Market
Introduction
Sustainability
Concluding Remarks from BCC
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
DANAHER CORP.
DIACARTA
EIKEN CHEMICAL CO. LTD.
EXACT SCIENCES CORP.
FREENOME HOLDINGS INC.
FUJIFILM HOLDINGS CORP.
GI-VIEW
GUARDANT HEALTH
HANGZHOU NOVAHEALTH TECHNOLOGY CO. LTD.
LABORATORY CORPORATION OF AMERICA HOLDINGS
LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
MAINZ BIOMED N.V.
NOVIGENIX SA
OLYMPUS CORP.
QUEST DIAGNOSTICS INC.
QUIDELORTHO CORP.
List of Tables
Summary Table : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 1 : Stage II Substages of Colorectal Cancer
Table 2 : Stage III Substages of Colorectal Cancer
Table 3 : Stage IV Substages of Colorectal Cancer
Table 4 : Regulatory Landscape for Different Parameters for Key Countries
Table 5 : Colonoscopy and Sigmoidoscopy Test Reimbursements, by Country, 2024
Table 6 : Stool DNA Test Reimbursements, by Country, 2024
Table 7 : Fecal Immunochemical Test Reimbursements, by Country, 2024
Table 8 : Fecal Occult Blood Test Reimbursements, by Country, 2024
Table 9 : Blood-based/Biomarker Test Reimbursements, by Country, 2024
Table 10 : Cancer Screening and Diagnostic Product Pipeline, 2024
Table 11 : Characteristics of CRC Screening Tests Currently Available in the U.S., 2024
Table 12 : Characteristics of Recommended Colorectal Cancer Screening Tests, 2024
Table 13 : Countries with Highest Colorectal Cancer Incidence and Rates, 2022
Table 14 : Successful Colorectal Cancer Screening Initiatives, 2004-2011
Table 15 : Examples of Product Launches and Approval in the Asia-Pacific Region, 2022
Table 16 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, Through 2029
Table 17 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 18 : Global Market for Colonoscopy and Sigmoidoscopy Tests, by Region, Through 2029
Table 19 : Global Market for Stool DNA Tests, by Region, Through 2029
Table 20 : Global Market for Blood-Based/Biomarker Tests, by Region, Through 2029
Table 21 : Global Market for Fecal Occult Blood Tests (FOBT), by Region, Through 2029
Table 22 : Global Market for Fecal Immunochemical Tests (FIT), by Region, Through 2029
Table 23 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 24 : Global Market for Hospitals and Clinics in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 25 : Global Market for Diagnostic Laboratories in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 26 : Global Market for Ambulatory Centers in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 27 : Global Market for At-home Care in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 28 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 29 : North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029
Table 30 : North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 31 : North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 32 : European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029
Table 33 : European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 34 : European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 35 : Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029
Table 36 : Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 37 : Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 38 : ROW Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 39 : ROW Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 40 : Top Products and Their Manufacturers in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2023
Table 41 : Select Strategic Alliances in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 42 : Select Acquisitions in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 43 : Major Business Expansion Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 44 : Major Grants and Funding Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 45 : Major Product Approvals, Launches, and Expansions in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 46 : Major Regulatory and Legal Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2024
Table 47 : Major Medicare and Insurance Coverage in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 48 : Recent ESG Highlights from Select Testing Services Providing Companies
Table 49 : ESG Rankings for a Few Service-Providing Companies, 2024
Table 50 : ESG Rankings for Major Product Manufacturing Companies, 2024
Table 51 : Information Sources for this Report
Table 52 : Glossary of Terms Used in the Colorectal Cancer Screening and Diagnostic Testing Service Market
Table 53 : Danaher Corp.: Company Snapshot
Table 54 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 55 : Danaher Corp.: Product Portfolio
Table 56 : Danaher Corp.: News/Key Developments, 2022
Table 57 : DiaCarta: Company Snapshot
Table 58 : DiaCarta: Product Portfolio
Table 59 : DiaCarta: News/Key Developments, 2023
Table 60 : Eiken Chemical Co. Ltd.: Company Snapshot
Table 61 : Eiken Chemical Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 62 : Eiken Chemical Co. Ltd.: Product Portfolio
Table 63 : Eiken Chemical Co. Ltd.: News/Key Developments, 2022
Table 64 : Exact Sciences Corp.: Company Snapshot
Table 65 : Exact Sciences Corp.: Financial Performance, FY 2022 and 2023
Table 66 : Exact Sciences Corp.: Product Portfolio
Table 67 : Exact Sciences Corp.: News/Key Developments, 2022-2024
Table 68 : Freenome Holdings Inc.: Company Snapshot
Table 69 : Freenome Holdings Inc.: News/ Key Developments, 2023 and 2024
Table 70 : Fujifilm Holdings Corp.: Company Snapshot
Table 71 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 72 : Fujifilm Holdings Corp.: Product Portfolio
Table 73 : GI-View: Company Snapshot
Table 74 : GI-View: Product Portfolio
Table 75 : Guardant Health: Company Snapshot
Table 76 : Guardant Health: Financial Performance, FY 2022 and 2023
Table 77 : Guardant Health: Product Portfolio
Table 78 : Guardant Health: News/Key Developments, 2024
Table 79 : Hangzhou NovaHealth Technology Co. Ltd.: Company Snapshot
Table 80 : Hangzhou NovaHealth Technology Co. Ltd.: Financial Performance, FY 2021 and 2022
Table 81 : Hangzhou NovaHealth Technology Co. Ltd.: Product Portfolio
Table 82 : Hangzhou NovaHealth Technology Co. Ltd.: News/Key Developments, 2022
Table 83 : Laboratory Corporation of America Holdings: Company Snapshot
Table 84 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 85 : Laboratory Corporation of America Holdings: Product Portfolio
Table 86 : Laboratory Corporation of America Holdings: News/Key Developments, 2024
Table 87 : Lepu Medical Technology (Beijing) Co. Ltd.: Company Snapshot
Table 88 : Lepu Medical Technology (Beijing) Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 89 : Lepu Medical Technology (Beijing) Co. Ltd.: Product Portfolio
Table 90 : Mainz Biomed N.V.: Company Snapshot
Table 91 : Mainz Biomed N.V.: Financial Performance, FY 2022 and 2023
Table 92 : Mainz Biomed N.V.: Product Portfolio
Table 93 : Mainz Biomed N.V.: News/Key Developments, 2023 and 2024
Table 94 : Novigenix SA: Company Snapshot
Table 95 : Novigenix SA: Product Portfolio
Table 96 : Olympus Corp.: Company Snapshot
Table 97 : Olympus Corp.: Financial Performance, FY 2022 and 2023
Table 98 : Olympus Corp.: Product Portfolio
Table 99 : Olympus Corp.: News/Key Developments, 2024
Table 100 : Quest Diagnostics Inc.: Company Snapshot
Table 101 : Quest Diagnostics Inc.: Financial Performance, FY 2022 and 2023
Table 102 : Quest Diagnostics Inc.: Product Portfolio
Table 103 : Quest Diagnostics Inc.: News/Key Developments, 2023
Table 104 : QuidelOrtho Corp.: Company Snapshot
Table 105 : QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023
Table 106 : QuidelOrtho Corp.: Product Portfolio
Table 107 : QuidelOrtho Corp.: News/Key Developments, 2024
List of Figures
Summary Figure : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
Figure 1 : Five-Year Survival Rates, by Colorectal Cancer Location
Figure 2 : Market Dynamics of Colorectal Cancer Screening and Diagnostic Testing
Figure 3 : Emerging Technologies in the Colorectal Cancer Screening and Diagnostic Testing Service Market
Figure 4 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, 2023
Figure 5 : Global Market for Colonoscopy and Sigmoidoscopy Tests, by Region, 2021-2029
Figure 6 : Global Market for Stool DNA Tests, by Region, 2021-2029
Figure 7 : Global Market for Blood Based/Biomarker Tests, by Region, 2021-2029
Figure 8 : Global Market for Fecal Occult Blood Tests (FOBT), by Region, 2021-2029
Figure 9 : Global Market for Fecal Immunochemical Tests (FIT), by Region, 2021-2029
Figure 10 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
Figure 11 : North American Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023
Figure 12 : U.S. Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 13 : Canadian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 14 : Mexican Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 15 : European Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023
Figure 16 : German Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 17 : U.K. Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 18 : French Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 19 : Italian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 20 : Spanish Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 21 : Rest of European Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 22 : Asia-Pacific Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023
Figure 23 : Chinese Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 24 : Japanese Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 25 : Indian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 26 : South Korean Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 27 : Australian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 28 : Rest of Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 29 : Total Number of Key Developments and Strategies, January 2022-November 2024
Figure 30 : Partnerships and Collaborations, January 2022-November 2024
Figure 31 : Acquisitions, January 2022-November 2024
Figure 32 : Business Expansions, January 2022-November 2024
Figure 33 : Funding and Grants, January 2022-November 2024
Figure 34 : Product Approvals, Launches and Expansions, January 2022-November 2024
Figure 35 : Regulatory and Legal Activities, January 2022-November 2024
Figure 36 : Medicare and Insurance Coverage, January 2022-November 2024
Figure 37 : Snapshot of ESG Pillars
Figure 38 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 39 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 40 : Eiken Chemical Co. Ltd.: Revenue Shares, by Product Type, FY 2023
Figure 41 : Exact Sciences Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 42 : Exact Sciences Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 43 : Fujifilm Holdings Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 44 : Fujifilm Holdings Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 45 : Guardant Health: Revenue Shares, by Business Unit, FY 2023
Figure 46 : Guardant Health: Revenue Shares, by Country/Region, FY 2023
Figure 47 : Hangzhou NovaHealth Technology Co. Ltd.: Revenue Shares, by Business Unit, FY 2022
Figure 48 : Hangzhou NovaHealth Technology Co. Ltd.: Revenue Shares, by Country/Region, FY 2022
Figure 49 : Laboratory Corporation of America Holdings: Revenue Shares, by Business Unit, FY 2023
Figure 50 : Laboratory Corporation of America Holdings: Revenue Shares, by Country/Region, FY 2023
Figure 51 : Lepu Medical Technology (Beijing) Co. Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 52 : Olympus Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 53 : Olympus Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 54 : Quest Diagnostics Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 55 : QuidelOrtho Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 56 : QuidelOrtho Corp.: Revenue Shares, by Country/Region, FY 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security